Product NDC: | 60505-0833 |
Proprietary Name: | Azelastine Hydrochloride |
Non Proprietary Name: | azelastine hydrochloride |
Active Ingredient(s): | 137 ug/1 & nbsp; azelastine hydrochloride |
Administration Route(s): | NASAL |
Dosage Form(s): | SPRAY, METERED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-0833 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077954 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100301 |
Package NDC: | 60505-0833-5 |
Package Description: | 1 BOTTLE, SPRAY in 1 CARTON (60505-0833-5) > 200 SPRAY, METERED in 1 BOTTLE, SPRAY |
NDC Code | 60505-0833-5 |
Proprietary Name | Azelastine Hydrochloride |
Package Description | 1 BOTTLE, SPRAY in 1 CARTON (60505-0833-5) > 200 SPRAY, METERED in 1 BOTTLE, SPRAY |
Product NDC | 60505-0833 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | azelastine hydrochloride |
Dosage Form Name | SPRAY, METERED |
Route Name | NASAL |
Start Marketing Date | 20100301 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | AZELASTINE HYDROCHLORIDE |
Strength Number | 137 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |